Malignant Plasma Cell Neoplasm
1 clinical trials · Condition
◉ Watch Malignant Plasma Cell Neoplasm
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma (NCT05336383) | M.D. Anderson Cancer Center | 2022-05-31 |
Track Malignant Plasma Cell Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.